1 – 10 of 259
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
BAY 81-8973 Demonstrates Long-Term Safety and Efficacy in Children With Severe Haemophilia A : Results From the LEOPOLD Kids Extension Study
- Contribution to journal › Article
-
Mark
Hemophilia B Leyden : characteristics and natural history in the International Pediatric Network of Hemophilia Management Registry
- Contribution to journal › Article
-
Mark
Blood Group O Does Not Increase the Risk of Inhibitors in Severe Haemophilia A : Data from the PedNet Study Group
- Contribution to journal › Article
- 2024
-
Mark
Factor VIII genotype and the risk of developing high-responding or low-responding inhibitors in severe hemophilia A : data from the PedNet Hemophilia Cohort of 1,202 children
- Contribution to journal › Article
-
Mark
Clinical Implications of Discrepancy between One-stage Clotting and Chromogenic Factor IX Activity in Haemophilia B
- Contribution to journal › Article
-
Mark
Recombinant factor IX Fc for the treatment of hemophilia B
- Contribution to journal › Scientific review
-
Mark
International Prophylaxis Study Group (IPSG) haemophilia joint MRI scale version 2.0
- Contribution to journal › Letter
-
Mark
Origin of pathogenic variant and mosaicism in families with a sporadic case of haemophilia B
- Contribution to journal › Article
-
Mark
Prophylactic Treatment of Children with Hemophilia in Sweden
- Contribution to journal › Scientific review
- 2023
-
Mark
Primary prophylaxis in children with severe haemophilia A and B-Implementation over the last 20 years as illustrated in real-world data in the PedNet cohorts
- Contribution to journal › Article
